Adjuvant chemotherapy for rectal cancer: current evidence and recommendations for clinical practice

Rectal cancer is the 8th most common tumour and the 9th leading cause of cancer-related deaths worldwide [1]. While substantial heterogeneity exists with regard to the anatomical landmarks used for the definition of these tumours, rectal cancers account for approximately 40% of all colorectal malignancies overall. Of note, they are the most common colorectal tumour in people
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Hot Topic Source Type: research